glp 1 osa Impact of Glucagon-Like Peptide-1 Analogues in the Treatment of Obstructive Sleep Apnoea: A Pro/Con Debate Did You Know? The FDA

Retatrutide's pending approval might change the landscape, but patients should remain in communication with their healthcare providers about cost expectations and insurance coverage

Initial reviews at 24 weeks allow early identification of side effects and provide opportunities for patient support and education

10.1038/s41467-022-31328-x

Companies like Hims & Hers, Ro, Noom Med, and dozens of smaller platforms competed on how quickly they could get a patient from online questionnaire to prescription in hand often in 24 to 48 hours, with minimal ongoing clinical involvement

If you plan to stay on treatment for years, and the data increasingly suggests you should, then the monthly expense matters as much as the clinical trial data

Joel Habener, using newly available basic research tools, searched for the gene that makes a hormone called glucagon